glutathione pathway to triple negative cancer Dual metabolic targeting liposomes potentiate triple-negative breast radiosensitivity via glucose and starvation Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



